Stories
Slash Boxes
Comments

SoylentNews is people

Politics
posted by Fnord666 on Sunday May 20 2018, @01:12AM   Printer-friendly
from the dishonor-on-you,-dishonor-on-your-cow dept.

Submitted via IRC for Runaway1956

Update 5/17/2018: The FDA has now launched the website listing the names of brand name drugs and their makers who have stood in the way of generic drug companies trying to make more affordable alternatives. You can view the list here. It includes notable medications, such as Accutane (for acne), Methadone (used for opioid dependency), and Tracleer (to treat high blood pressure in the lungs). The brand name drug makers to be shamed includes big hitters such as Celgene Corp, GlaxoSmithKline, Pfizer, Valeant Pharmaceuticals International, Gilead Sciences Inc, and Actelion Pharmaceuticals Ltd, now a Johnson & Johnson company. Our original story, published May 16, is unedited below.

The Food and Drug Administration plans this week to effectively begin publicly shaming brand-name drug companies that stand in the way of competitors trying to develop cheaper generic drugs.

FDA Commissioner Scott Gottlieb told reporters on Monday and Tuesday that the agency will unveil a website on Thursday, May 17 that names names of such companies. More specifically, the website will publicly reveal the identity of 50 branded drugs and their makers that have blocked generic development. The website will also be updated "on a continuous basis" to list additional names.

In fielding questions from reporters, Gottlieb denied that the effort was a form of public shaming. "I don't think this is publicly shaming," Gottlieb said, according to S&P Global Market Intelligence. "I think this is providing transparency in situations where we see certain obstacles to timely generic entry."

Source: https://arstechnica.com/science/2018/05/fda-to-start-naming-names-of-pharma-companies-blocking-cheaper-generics/


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 5, Informative) by MostCynical on Sunday May 20 2018, @02:48AM (2 children)

    by MostCynical (2589) on Sunday May 20 2018, @02:48AM (#681750) Journal

    Your faith in pharmaceutical companies even wanting to invest in *cures*, let alone bother if they obscure, rare diseases, is... delusional.
    Unless your incurable condition is "stupidity", or "delusional optimism".

    --
    "I guess once you start doubting, there's no end to it." -Batou, Ghost in the Shell: Stand Alone Complex
    Starting Score:    1  point
    Moderation   +3  
       Informative=3, Total=3
    Extra 'Informative' Modifier   0  
    Karma-Bonus Modifier   +1  

    Total Score:   5  
  • (Score: 0) by Anonymous Coward on Sunday May 20 2018, @05:14AM (1 child)

    by Anonymous Coward on Sunday May 20 2018, @05:14AM (#681783)

    Why would a pharma company want to kill off the cash cow that brings its insurance card to the pharmacy register monthly?

    Everything is going to a rent-seeking subscription base these days... including life itself. Usually monthly.

    ( You can't even buy a can of beer these days... you can only rent it for an hour or so! )

    • (Score: 1) by khallow on Sunday May 20 2018, @12:50PM

      by khallow (3766) Subscriber Badge on Sunday May 20 2018, @12:50PM (#681843) Journal
      Why would they want to cure a cash cow on which they have a monopoly position?